Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Dose Escalation and Expansion Study of the Safety and Pharmacokinetics of XL114 in Subjects with Non-Hodgkins Lymphoma
Sponsored by Exelixis Pharmaceuticals, Incorporated
Active
$236.5K Funding
6 People
External
Related Topics
pharmacokinetics,
oncology,
clinical trial,
safety,
dose escalation
People
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Abhijeet Kumar
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
Michele Chu-Pilli
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Patricia Robles Quihuis
(CD)
Cancer Center Division
﹒Research Nurse III
